Caritas Cancer Institute, Kottayam, Kerala
drjojovjoseph@gmail.com
Connect on WhatsApp

Articles

Sentinel Lymphnode Biopsy in Breast Cancer Surgery

Sentinel node biopsy is a surgical procedure commonly used in the diagnosis and treatment of breast cancer. It involves the removal and examination of the sentinel lymph node, which is the first lymph node to which cancer cells are most likely to spread from the primary tumor. This procedure has become an important tool in breast cancer management, as it allows for accurate staging of the disease and determination of appropriate treatment options, while minimizing the potential complications associated with more invasive lymph node dissection.

Breast cancer can spread to the lymph nodes, which are part of the body's immune system and are located throughout the body, including under the arms. Lymph nodes act as filters for substances, including cancer cells, that are transported through lymphatic vessels. When cancer cells break away from the primary tumor, they can travel through these vessels and potentially reach the lymph nodes. The presence or absence of cancer cells in the lymph nodes is an important factor in determining the stage and prognosis of breast cancer.

Traditionally, axillary lymph node dissection (ALND) was performed to remove a large number of lymph nodes from the armpit area during breast cancer surgery. However, this procedure is associated with a higher risk of complications, including lymphedema (swelling of the arm), numbness, and shoulder mobility issues. Moreover, the majority of women who undergo ALND have no evidence of cancer spread to the lymph nodes, meaning that their lymph nodes were unnecessarily removed.

Sentinel node biopsy (SNB) is a more targeted approach that aims to identify and remove only the sentinel lymph node(s) that cancer cells are most likely to spread to from the primary tumor. It involves injecting a radioactive tracer and/or a blue dye into the breast, which helps to identify the sentinel node(s). During surgery, the surgeon uses a Geiger counter or a gamma probe to locate the sentinel node(s) and remove them for further examination. If cancer cells are found in the sentinel node(s), additional lymph nodes may be removed for a more comprehensive analysis.

Numerous studies have demonstrated the accuracy of sentinel node biopsy in predicting the status of the axillary lymph nodes. If the sentinel node(s) are free of cancer cells, it is highly likely that the remaining lymph nodes in the axilla are also cancer-free. This allows for a more precise diagnosis and staging of the disease, sparing many women from the unnecessary morbidity associated with ALND.

For patients with early-stage breast cancer, sentinel node biopsy has become the standard of care. It allows for a more targeted and less invasive approach to lymph node removal, reducing the risk of complications and improving quality of life post-surgery. It also facilitates individualized treatment plans based on accurate staging and better prediction of recurrence risk.

In conclusion, sentinel node biopsy has revolutionized the surgical management of breast cancer. By minimizing the unnecessary removal of lymph nodes, it improves patient outcomes and reduces the potential for complications. This procedure plays a crucial role in accurately staging breast cancer and tailoring appropriate treatment options for each patient, ultimately improving survival rates and quality of life.